2Takaaki Ito,Hitoshi Kitamura,Nobuo Nakamura,Yoichi Kameda,Masayoshi Kanisawa. A comparative study of vascular proliferation in brain metastasis of lung carcinomas[J] 1993,Virchows Archiv A Pathological Anatomy and Histopathology(1):13～17
3Rifkin DB, Moscatelli D. Resent developments in the cell bi-ology of basic fibroblast growth factor[J]. J Cell Biol, 1989, 109:1-6.
4Dow Jk, deVere White RW. Fibroblast growth factor-2:its stucture and property, paracrine function, tumor angiogenesis and prostate-related mitogenic and oncogenic functions [J]. Urology, 2000, 55(4) :800-806.
5Jacquemier J, Adelaide J, Pare P, et al. Expression of the FGFR-I gene in human breast carcinoma ceils [J]. Int J Cancer, 1994, 59(3) :373-378.
6Weiss J, Sos ML,Seidel M, et al. Frequent and focal FG- FR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer[J]. SciTransl Med, 2010, 2(62) : 62-93.
7Dutt A, Ramos AH, Hammerman PS, et al. Inhibitor-sen- sitive FGFR1 amplification in human non-small cell lung cancer[J]. PLoS One, 2011,6(6) : e20351.
8Gravdal K, Halvorsen OJ, Haukaas SA, et al. Expression of bFGF/FGFR1 and vascular proliferation related to clin- icopathologic features and tumor progress in localized pros- tate cancer[J]. Virchows Arch, 2006, 448(1): 68-74.
9Vesely D, Astl J, Matucha P, et al. Serum levels of angio- genic growth factors in patients with thyroid gland tumors and parathyroid adenoma[J]. Neuro Endocrinol Lett, 2003, 24(6) : 417-419.
